Business Standard

Expensive valuations may cap near-term upside in chemical stocks: Analysts

However, they remain positive on the sector's long-term growth story on the back of ramp-up in China's environmental inspections and specialty chemical players having a healthy margin of safety

pharma, chemicals
Premium

Nikita Vashisht New Delhi
The breathtaking rally in chemical stocks may be heading towards a short-term breather as valuations turn expensive and financial performance plateaus, caution analysts. However, they remain positive on the sector’s long-term growth story on the back of ramp-up in China’s environmental inspections and specialty chemical players having a healthy margin of safety.

An analysis of March quarter results of leading chemical companies such as Tata Chemicals, Navin Fluorine, and SRF show contraction in margins, “possibly reflecting full/partial exhaustion of low cost inventories and influx of high priced raw material”, say analysts.

“During earlier quarters, operating costs remained low aided by

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in